A novel drug re-positioning strategy for Parkinson’s: Simultaneous, high content screening for translatable small molecules which are beneficial for mitochondrial and lysosomal dysfunction in primary fibroblasts from Parkinson’s patients

A novel drug re-positioning strategy for Parkinson’s: Simultaneous, high content screening for translatable small molecules which are beneficial for mitochondrial and lysosomal dysfunction in primary fibroblasts from Parkinson’s patients

Fellowships
United Kingdom
Parkinson’s disease & PD-related disorders
2016